Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization has announced. The Men5CV vaccine offers a powerful shield against the five major strains of the meningococcal bacteria that cause the disease. Known by the brand name MenFive, it provides broader protection than the vaccine currently used in much of Africa.
The Path to Scale dashboard, developed in a partnership between the Rights and Resources Initiative (RRI) and the Rainforest Foundation Norway (RFN), provides information on funding from 133 donors since 2011 based on publicly available information. According to the developers, this publicly accessible dashboard will help donors, NGOs and rights holders identify critical funding gaps and opportunities in global efforts to secure communities’ rights.
According to a recent study from Our World In Data, in the early-to-mid 20th century, the average annual death toll from disasters was very high, often climbing to over a million. In recent decades, such deaths are typically fewer than 20,000 people, even as natural disasters become more frequent and more extreme.
A massive subsidy program to help Indian households install rooftop solar panels in their homes and apartments aims to provide 30 gigawatt hours of solar power to the nation’s inventory. The scheme, called PM-Surya Ghar, will provide free electricity to 10 million homes according to estimates, and the designing of a national portal will streamline the process of installation and payment.
Commonly called “forever chemicals,” PFAS are synthetic chemicals found nearly everywhere — in air, water, and soil — and can take thousands of years to break down in the environment.
The EPA has stated there is no safe level of exposure to PFAS without risk of health impacts, but now it will require that public water utilities test for six different types of PFAS chemicals to reduce exposure in drinking water. The new standards will reduce PFAS exposure for 100 million people, according to the EPA, and prevent thousands of deaths and illnesses.
The women, mostly in their 70s, said that their age and gender made them particularly vulnerable to the effects of heatwaves linked to climate change. The court said Switzerland’s efforts to meet its emission reduction targets had been woefully inadequate. The ruling is binding and can trickle down to influence the law in 46 countries in Europe.
Solar generation in Texas was 3.26 terawatt hours (TWh) in the month of March, beating the 2.96 TWh sent out by coal-fired generators. It’s the first time solar has beaten coal over a whole month in Texas, the largest user of coal for power generation of any state in the U.S. The share of coal generation in Texas is now declining rapidly, from 40% more than a decade ago and 30% in 2017 to 13.9% in 2023.
The Shark Reef Aquarium on the Las Vegas Strip in Nevada has been sending zebra shark eggs to Indonesia’s Raja Ampat. Researchers hope to release 500 zebra sharks into the wild within 10 years in an effort to support a large, genetically diverse breeding population.
A survey estimated the zebra shark had a population of 20 spread throughout the Raja Ampat archipelago, making the animal functionally extinct in the region.
The U.N. Human Rights Council has issued its first-ever resolution supporting the rights of intersex people. An estimated 1.7% of infants are born intersex — many are forced to undergo irreversible surgeries to “correct” their anatomy and are subject to stigma and discrimination. The resolution directs the U.N. High Commissioner for Human Rights to prepare a report on the challenges intersex people face and the best ways to ensure intersex people’s “highest attainable standard of physical and mental health.”
Thousands of people across the U.K. who are worried about their memory will receive blood tests for dementia in two trials that doctors hope will help to revolutionize the low diagnosis rate. Teams from the University of Oxford and University College London will lead the trials to research the use of cheap and simple tests to detect proteins for people with early stages of dementia or problems with cognition, with the hope of speeding up diagnosis and reaching more people.
